• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Unicycive Therapeutics Inc (NQ: UNCY )

    0.3800 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.3800
    Bid (Size) 0.3775 (3)
    Ask (Size) 0.3970 (1)
    Prev. Close 0.3800
    Today's Range 0.3800 - 0.3800
    52wk Range 0.2020 - 1.818
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Life Sciences Virtual Investor Forum Agenda Announced for September 19th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire

    Performance

    YTD
    -57.10%
    -57.10%
    1 Month
    +19.53%
    +19.53%
    3 Month
    -16.85%
    -16.85%
    6 Month
    -73.97%
    -73.97%
    1 Year
    -57.16%
    -57.16%

    More News

    Read More
    Where Unicycive Therapeutics Stands With Analysts
    Via Benzinga
    UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    The 7 Most Undervalued Penny Stocks to Buy in October 2023
    Via InvestorPlace
    Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
    From Unicycive Therapeutics, Inc.
    Via GlobeNewswire
    Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
    From Unicycive Therapeutics, Inc.
    Via GlobeNewswire
    Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
    From Unicycive Therapeutics, Inc.
    Via GlobeNewswire
    CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
    Via ACCESSWIRE
    60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.